MedTech poised to outperform in 2027, Leerink says as Abbott upgraded
at seekingalpha.com (Thu, 19-Nov 10:49 AM)
Abbott launches 585-patient CROWN-MV pivotal trial for its catheter-delivered Cephea mitral valve replacement
Market Chameleon (Thu, 29-Oct 9:19 AM)
Abbott Reaffirms 2026 EPS Outlook as Q3 Comparable Sales Rise 7.0% and New Approvals Expand the Pipeline
Market Chameleon (Wed, 21-Oct 11:49 AM)
Abbott Reaffirms 2026 EPS Outlook as 3Q Comparable Sales Rise 7.0% and Devices/Diagnostics Lead Growth
Market Chameleon (Wed, 21-Oct 7:52 AM)